Impact Corelab to Move to New Corporate Headquarters in Sacramento
Impact Corelab, Inc. (ICI) announced the completion of work on its new corporate headquarters suite in Sacramento. In March, the company plans to move staff and operations into the facility, which adjoins the offices of Radiological Associates of Sacramento (RAS), whose radiologists provide specialized medical resources and support for customers of ICI’s imaging corelab services. The move is expected to enable a high degree of strategic collaboration between the two firms.
Located at 1500 Expo Parkway in Sacramento, the newly built office suite will allow ICI to concentrate its core activities in one location, including executive leadership, imaging operations, radiology read workstations, business development, data hosting/management, customer support and project management.
“We are pleased with the completion of our new headquarters space,” said Dr. Benjamin Franc M.D., M.S., acting CEO and Chairman of the Board. “This is an opportunity for us to consolidate the key corporate functions that will help fuel future growth as well as providing us with the proximity we wanted to enable close collaboration with our radiological affiliate, RAS, to serve the needs of ICI’s growing customer base.”
RAS’ team of 1,000 radiology professionals includes doctors, radiology specialists, and project managers to help support customers of ICI, which combines cloud-based data on demand technology with radiological services to deliver transparency, reliability, and query reduction for sponsors and CROs in image-based trials.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
